Cisen Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603367
  • 1d-0.46%
  • 1w3.14%
  • 1m5.29%
  • 1y4.14%
ATH
  • ATH Price$28.86
  • ATH Date2017-10-17
  • % since ATH-47.60%
  • % to ATH90.86%
ATL
  • ATL Price$10.39
  • ATL Date2022-04-26
  • % from ATL45.48%
  • Last Low Price$10.3935
  • Last Low Date2022-04-26
  • % From Last Low45.48%
IPO
  • IPO Price$13.99
  • % Current ROI USD108.08%
  • ATH Price$28.86
  • % ROI ATH 27,764.95%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603367"]

Key Data [addtoany]

Current price $15.12
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $15.43/$14.87
Volume 3,204,208.00
Previous Close $15.19
52 Week High/Low $16.5524/$11.34
Market Cap 6,877,651,968.00
P/E Ratio 15.3434
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0221
$15.12
[addtoany]

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally.
The company’s chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products.
It also engages in the formulation, development, manufacturing, and marketing of generic pharmaceutical products.
The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. is based in Jining, the People’s Republic of China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity